alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32
                                                                ----------


                  CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                         AND CHIEF FINANCIAL OFFICER
                     PURSUANT TO 18 U.S.C. SECTION 1350,
                    AS ADOPTED PURSUANT TO SECTION 906 OF
                        THE SARBANES-OXLEY ACT OF 2002

            In connection with the Quarterly Report on Form 10-QSB
of Touchstone Applied Science Associates, Inc. (the "Company"),
for the quarter ended April 30, 2006, as filed with the
Securities and Exchange Commission on the date hereof (the
"Report"), I, Andrew L. Simon, President, Chief Executive
Officer and Chief Financial Officer of the Company, hereby
certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to 906
of the Sarbanes-Oxley Act of 2002, Touchstone Applied Science
Associates, Inc., to the best of my knowledge, that:

            1.	The Report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of
1934; and

            2.	The information contained in the Report fairly
presents, in all material respects, the financial condition and
results of operations of the Company.

Dated:  June 14, 2006                 /s/ ANDREW L. SIMON
                                       ------------------------
                                       Andrew L. Simon,
                                       President, Chief Executive
                                       Officer and Chief
                                       Financial Officer



A signed original of this written statement required by Section
906 has been provided to Touchstone Applied Science Associates,
Inc. and will be retained by Touchstone Applied Science
Associates, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.
I

104TH CONGRESS

2D SESSION H. R. 3367

To amend the National Highway System Designation Act of 1995 to increase

the number of States that may participate in the State infrastructure

bank pilot program authorized by that Act.

IN THE HOUSE OF REPRESENTATIVES

APRIL 30, 1996

Mr. SCHUMER introduced the following bill; which was referred to the

Committee on Transportation and Infrastructure

A BILL

To amend the National Highway System Designation Act

of 1995 to increase the number of States that may

participate in the State infrastructure bank pilot program authorized by that Act.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. STATE INFRASTRUCTURE BANK PILOT PRO4 GRAM.

5 Section 350(a)(1) of the National Highway System

6 Designation Act of 1995 (23 U.S.C. 101 note; 109 Stat.
2

•HR 3367 IH

1 619) is amended by striking ‘‘10 States’’ and inserting

2 ‘‘20 States’’.

Æ
I

104TH CONGRESS

1ST SESSION H. R. 324

To amend the Federal Election Campaign Act of 1971 to require certain

disclosures with respect to phone bank communications.

IN THE HOUSE OF REPRESENTATIVES

JANUARY 4, 1995

Mrs. MALONEY (for herself, Mr. PETRI, Ms. VELA ́ZQUEZ, Mr. OWENS, and

Mr. SERRANO) introduced the following bill; which was referred to the

Committee on House Oversight

A BILL

To amend the Federal Election Campaign Act of 1971 to

require certain disclosures with respect to phone bank

communications.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Voters’ Right to Know

5 Act’’.

6 SEC. 2. DISCLOSURE REQUIREMENT FOR PHONE BANK

7 COMMUNICATIONS.

8 Section 318(a) of the Federal Election Campaign Act

9 of 1971 (2 U.S.C. 441d(a)) is amended, in the matter be-
2

•HR 324 IH

1 fore paragraph (1), by inserting after ‘‘broadcasting sta2 tion’’ the following: ‘‘phone bank,’’.

Æ
Editorial Note on Part 431
Editorial Note: Nomenclature changes to part 431 appear at 75 FR 48852, Aug. 11, 2010.

§ 431.621 State requirements with respect to nursing facilities. ( a ) *Basis and purpose.* This section implements sections 1919(b)(3)(F) and 1919(e)(7) of the Act by specifying the terms of the agreement the State must have with the State mental health and Intellectual Disability authorities concerning the operation of the State's preadmission screening and annual resident review (PASARR) program.
( b ) *State plan requirement.* The State plan must provide that the Medicaid agency has in effect a written agreement with the State mental health and Intellectual Disability authorities that meets the requirements specified in paragraph (c) of this section.
( c ) *Provisions required in an agreement.* The agreement must specify the respective responsibilities of the agency and the State mental health and Intellectual Disability authorities, including arrangements for— ( 1 ) Joint planning between the parties to the agreement;
( 2 ) Access by the agency to the State mental health and Intellectual Disability authorities' records when necessary to carry out the agency's responsibilities;
( 3 ) Recording, reporting, and exchanging medical and social information about individuals subject to PASARR;
( 4 ) Ensuring that preadmission screenings and annual resident reviews are performed timely in accordance with §§ 483.112(c) and 483.114(c) of this part;
( 5 ) Ensuring that, if the State mental health and Intellectual Disability authorities delegate their respective responsibilities, these delegations comply with § 483.106(e) of this part;
( 6 ) Ensuring that PASARR determinations made by the State mental health and Intellectual Disability authorities are not countermanded by the State Medicaid agency, except through the appeals process, but that the State mental health and Intellectual Disability authorities do not use criteria which are inconsistent with those adopted by the State Medicaid agency under its approved State plan;
( 7 ) Designating the independent person or entity who performs the PASARR evaluations for individuals with MI; and
( 8 ) Ensuring that all requirements of §§ 483.100 through 483.136 are met.
[57 FR 56506, Nov. 30, 1992; 58 FR 25784, Apr. 28, 1993]
# C_2006131EN.01003702.xml

| 3.6.2006 | EN | Official Journal of the European Union | C 131/37 |
| --- | --- | --- | --- |

3.6.2006

EN

Official Journal of the European Union

C 131/37

---

Judgment of the Court of First Instance of 5 April 2006 — Degussa v Commission

(Case T-279/02) (1)

1

(Competition - Article 81 EC - Cartels - Methionine market - Unique and continuous nature of the infringement - Fine - Guidelines for calculating the amount of fines - Gravity and duration of the infringement - Cooperation during the administrative procedure - Article 15(2) of Regulation No 17/62 - Presumption of innocence)

(2006/C 131/68)

Language of the case: German

Parties

Applicant: Degussa AG (Düsseldorf, Germany) (represented by: R. Bechtold, M. Karl and C. Steinle, lawyers)

Applicant:

Defendant: Commission of the European Communities (represented by: A. Bouquet and W. Mölls, agents, assisted by H.-J. Freund, lawyer)

Defendant:

Intervener in support of the defendant: Council of the European Union (represented by: E. Karlsson and S. Marquardt, agents)

Re:

Primarily, an application for annulment of Commission Decision 2003/674/EC of 2 July 2002 relating to a proceeding pursuant to Article 81 of the EC Treaty and Article 53 of the EEA Agreement (Case C.37.519 — Methionine) (OJ 2003 L 255, p.1) and, in the alternative, an application for reduction of the fine imposed on the applicant by this decision.

Operative part of the judgment

The Court:

| 1. | Reduces to EUR 91 125 000 the fine imposed on the applicant by Article 3 of Commission Decision 2003/674/EC of 2 July 2002 relating to a proceeding pursuant to Article 81 of the EC Treaty and Article 53 of the EEA Agreement (Case C.37.519 — Methionine); |
| --- | --- |

1.

Reduces to EUR 91 125 000 the fine imposed on the applicant by Article 3 of Commission Decision 2003/674/EC of 2 July 2002 relating to a proceeding pursuant to Article 81 of the EC Treaty and Article 53 of the EEA Agreement (Case C.37.519 — Methionine);

| 2. | Dismisses the remainder of the application; |
| --- | --- |

2.

Dismisses the remainder of the application;

| 3. | Orders the applicant to pay its own costs and 75 % of the costs incurred by the Commission; |
| --- | --- |

3.

Orders the applicant to pay its own costs and 75 % of the costs incurred by the Commission;

| 4. | Orders the Commission to pay 25 % of its own costs; |
| --- | --- |

4.

Orders the Commission to pay 25 % of its own costs;

| 5. | Orders the Council to pay its own costs. |
| --- | --- |

5.

Orders the Council to pay its own costs.

---

(1)  OJ C 274 of 9.11.2002

1

---
§ 425.510 Application of the Alternative Payment Model Performance Pathway (APP) to Shared Savings Program ACOs for performance years beginning on or after January 1, 2021. ( a ) *General.* ( 1 ) CMS establishes quality performance measures to assess the quality of care furnished by the ACO. If the ACO demonstrates to CMS that it has satisfied the quality performance requirements in this subpart, and the ACO meets all other applicable requirements, the ACO is eligible to receive shared savings.
( 2 ) CMS seeks to improve the quality of care furnished by ACOs over time by specifying higher standards, new measures, or both.
( b ) *Quality reporting.* ACOs must report quality data via the APP established under § 414.1367 of this chapter, according to the method of submission established by CMS.
( c ) *Audit and validation of data.* CMS retains the right to audit and validate quality data reported by an ACO under paragraph (b) of this section according to § 414.1390 of this chapter.
[85 FR 85041, Dec. 28, 2020]
Editorial Note on Part 411
Editorial Note: Nomenclature changes to part 411 appear at 71 FR 9471, Feb. 24, 2006

§ 411.4 Services for which neither the beneficiary nor any other person is legally obligated to pay. ( a ) *General rule.* Except as provided in § 411.8(b) (for services paid by a governmental entity), Medicare does not pay for a service if— ( 1 ) The beneficiary has no legal obligation to pay for the service; and
( 2 ) No other person or organization (such as a prepayment plan of which the beneficiary is a member) has a legal obligation to provide or pay for that service.
( b ) *Special conditions for services furnished to individuals in custody of penal authorities.* Individuals who are in custody include, but are not limited to, individuals who are under arrest, incarcerated, imprisoned, escaped from confinement, under supervised release, on medical furlough, required to reside in mental health facilities, required to reside in halfway houses, required to live under home detention, or confined completely or partially in any way under a penal statute or rule. Payment may be made for services furnished to individuals or groups of individuals who are in the custody of police or other penal authorities or in the custody of a government agency under a penal statute only if the following conditions are met: ( 1 ) State or local law requires those individuals or groups of individuals to repay the cost of medical services they receive while in custody.
( 2 ) The State or local government entity enforces the requirement to pay by billing all such individuals, whether or not covered by Medicare or any other health insurance, and by pursuing collection of the amounts they owe in the same way and with the same vigor that it pursues the collection of other debts.
[54 FR 41734, Oct. 11, 1989, as amended at 72 FR 47410, Aug. 22, 2007]
**EXHIBIT NO. 11**

**STATEMENT OF COMPUTATION OF EARNINGS PER SHARE**

|                                      |   | **Year Ended December 31, 2002** |      |
|-------------------------------------------|--------|----------------------------------|-----------|
|                                      |   |                                  |      |
|                                      |   | **Shares**                       |      | **Earnings Per Share** |   |
|                                      |   |                                  |      |  |   |
| Basic Weighted Average Shares Outstanding |   |                             | 7,161,609 |   |   | 1.20 |   |
| Diluted                                   |   |                             | 7,161,609 |   |   | 1.20 |   |
| Average Shares Outstanding                |   |                             | 7,161,609 |   |   | 1.20 |   |
| Common Stock Equivalents                  |   |                             | 7,161,609 |   |   | 1.20 |   |
|                                      |   |                             |      |
|                                      |   | **Year Ended December 31, 2001** |      |
|                                      |   |                                  |      |
| Basic Weighted Average Shares Outstanding |   |                             | 7,185,993 |   |   |   |   |
| Diluted                                   |   |                             | 7,185,993 |   |   |   |   |
| Average Shares Outstanding                |   |                             | 7,185,993 |   |   |   |   |
| Common Stock Equivalents                  |   |                             | 7,185,993 |   |   |   |   |
§ 412.104 Special treatment: Hospitals with high percentage of ESRD discharges. Cross Reference
Link to an amendment published at 89 FR 69911 , Aug. 28, 2024.
( a ) *Criteria for classification.* CMS provides an additional payment to a hospital for inpatient services provided to ESRD beneficiaries who receive a dialysis treatment during a hospital stay, if the hospital has established that ESRD beneficiary discharges, excluding discharges classified into any of the following MS-DRGs, where the beneficiary received dialysis services during the inpatient stay, constitute 10 percent or more of its total Medicare discharges: ( 1 ) MS-DRG 019 (Simultaneous Pancreas/Kidney Transplant with Hemodialysis).
( 2 ) MS-DRGs 650 and 651 (Kidney Transplant with Hemodialysis with MCC, without MCC, respectively).
( 3 ) MS-DRGs 682, 683, and 684 (Renal Failure with MCC, with CC, without CC/MCC, respectively).
( b ) *Additional payment.* A hospital that meets the criteria of paragraph (a) of this section is paid an additional payment for each ESRD beneficiary discharge except those excluded under paragraph (a) of this section. ( 1 ) The payment is based on the estimated weekly cost of dialysis and the average length of stay of ESRD beneficiaries for the hospital.
( 2 ) The estimated weekly cost of dialysis is the average number of dialysis sessions furnished per week during the 12-month period that ended June 30, 1983 multiplied by the average cost of dialysis for the same period.
( 3 ) The average cost of dialysis includes only those costs determined to be directly related to the dialysis service. (These costs include salary, employee health and welfare, drugs, supplies, and laboratory services.)
( 4 ) The average cost of dialysis is reviewed and adjusted, if appropriate, at the time the composite rate reimbursement for outpatient dialysis is reviewed.
( 5 ) The payment to a hospital equals the average length of stay of ESRD beneficiaries in the hospital, expressed as a ratio to one week, times the estimated weekly cost of dialysis multiplied by the number of ESRD beneficiary discharges except for those excluded under paragraph (a) of this section. This payment is made only on the Federal portion of the payment rate.
[50 FR 12741, Mar. 29, 1985, as amended at 57 FR 39824, Sept. 1, 1992; 69 FR 49244, Aug. 11, 2004; 73 FR 48755, Aug. 19, 2008; 85 FR 59021, Sept. 18, 2020]
§ 425.226 Annual participation elections. ( a ) *General.* This section applies to ACOs in agreement periods beginning on July 1, 2019, and in subsequent years. Before the start of a performance year, an ACO may make elections related to its participation in the Shared Savings Program, as specified in this section, effective at the start of the applicable performance year and for the remaining years of the agreement period, unless superseded by a later election in accordance with this section. ( 1 ) *Selection of beneficiary assignment methodology.* An ACO may select the assignment methodology that CMS employs for assignment of beneficiaries under subpart E of this part. An ACO may select either of the following: ( i ) Preliminary prospective assignment with retrospective reconciliation, as described in § 425.400(a)(2).
( ii ) Prospective assignment, as described in § 425.400(a)(3).
( 2 ) *Selection of BASIC track level.* An ACO participating under the BASIC track in the glide path may select a higher level of risk and potential reward, as provided in this section. ( i ) An ACO participating under the BASIC track's glide path may elect to transition to a higher level of risk and potential reward within the glide path than the level of risk and potential reward that the ACO would be automatically transitioned to in the applicable year as specified in § 425.605(d)(1). The automatic transition to higher levels of risk and potential reward within the BASIC track's glide path continues to apply to all subsequent years of the agreement period in the BASIC track.
( ii ) An ACO transitioning to a higher level of risk and potential reward under paragraph (a)(2)(i) of this section must meet all requirements to participate under the selected level of performance-based risk, including both of the following: ( A ) Establishing an adequate repayment mechanism as specified under § 425.204(f).
( B ) Selecting a MSR/MLR from the options specified under § 425.605(b).
( b ) *Election procedures.* ( 1 ) All annual elections must be made in a form and manner and according to the timeframe established by CMS.
( 2 ) ACO executive who has the authority to legally bind the ACO must certify the elections described in this section.
[83 FR 68066, Dec. 31, 2018]
CERTIFICATE OF AMENDMENT

                           GENERAL GENETICS CORORATION
--------------------------------------------------------------------------------
a  corporation  organized  and  existing  under  and by  virtue  of the  General
Corporation Law of the State of Delaware,

DOES HEREBY CERTIFY:

FIRST:  That a meeting of the Board of Directors of

                          GENERAL GENETICS CORPORATION
--------------------------------------------------------------------------------
resolutions  were  duly  adopted  setting  forth  a  proposed  amendment  of the
Certificate of Incorporation of said corporation, declaring said amendment to be
advisable  and calling a meeting of the  stockholders  of said  corporation  for
consideration thereof. The resolution setting forth the proposed amendment is as
follows:

      RESOLVED,   that  the   Certificate  of   Incorporation   of  this
      corporation  be amended  by changing the Articles thereof numbered
      " IV "  so  that,  as  amended,  said  Article  shall  be and read 
      ------ as follows:
 
     "The  total  number of shares of stock  which the  corporation  is
     ------------------------------------------------------------------
      authorized to issue is
      ----------------------

      Five Hundred Million  (500,000,000) shares all with a par value of
      ------------------------------------------------------------------
      one mil (.001).
      ---------------

SECOND:  That  thereafter,  pursuant to resolution of its Board of Directors,  a
special  meeting of the  stockholders  of said  corporation  was duly called and
held, upon notice in accordance with Section 222 of the General  Corporation Law
of the State of Delaware  at which  meeting  the  necessary  number of shares as
required by statute were voted in favor of the amendment.

THIRD: That said amendment was duly adopted in accordance with the provisions of
Section 242 of the General Corporation Law of the State of Delaware.

FOURTH:  That the capital of said  corporation  shall not be reduced under or by
reason of said amendment.

IN WITNESS WHEREOF, said          GENERAL GENETICS CORPORATION
                         -------------------------------------------------------
has  caused  this  certificate  to  be signed  by  its authorized officer   this
      14th        day of       June      , 1996.
----------------         ----------------    --  

                              BY:       /s/  Hans Morkner
                                  ----------------------------------------------
                                  Authorized Officer
     STATE OF DELAWARE
    SECRETARY OF STATE
DIVISION OF CORPORATIONS
FILED 09:00 AM 06/17/1996
   960175736 - 938627
# C_2006131EN.01003701.xml

| 3.6.2006 | EN | Official Journal of the European Union | C 131/37 |
| --- | --- | --- | --- |

3.6.2006

EN

Official Journal of the European Union

C 131/37

---

Assignment of Judges to Chambers

(2006/C 131/67)

At its plenary meeting on 8 May 2006, the Court of First Instance decided, following the taking up of his duties by Mr Moavero Milanesi, to amend as follows the decision of the plenary meeting of 7 July 2005 on the assignment of Judges to chambers:

For the period from 8 May 2006 to 30 September 2006, the following are assigned:

| | to the Fourth Chamber (Extended Composition), sitting with five Judges:

  H. Legal, President of the Chamber, P. Lindh, I. Wiszniewska-Bialecka, V. Vadapalas and M. Milanesi, Judges; |
| --- | --- |

to the Fourth Chamber (Extended Composition), sitting with five Judges:

to the Fourth Chamber (Extended Composition), sitting with five Judges:

H. Legal, President of the Chamber, P. Lindh, I. Wiszniewska-Bialecka, V. Vadapalas and M. Milanesi, Judges;

| | to the Fourth Chamber, sitting with three Judges:

  H. Legal, President of the Chamber






  (a) | P. Lindh and V. Vadapalas, Judges |
| --- | --- | --- |

to the Fourth Chamber, sitting with three Judges:

to the Fourth Chamber, sitting with three Judges:

H. Legal, President of the Chamber

(a)

P. Lindh and V. Vadapalas, Judges

| (b) | I. Wiszniewska-Bialecka and M. Milanesi, Judges |
| --- | --- |

(b)

I. Wiszniewska-Bialecka and M. Milanesi, Judges

---
EXHIBIT 21

		      SUBSIDIARIES OF THE REGISTRANT 

<PAGE>

				EXHIBIT 21

		      SUBSIDIARIES OF THE REGISTRANT 


The following is a list of subsidiaries of the Company at December 31, 1996 and
all are included in the Company's consolidated financial statements:


					  Jurisdiction        Percentage of
					       of          Voting Securities
Subsidiary (1)(2)                         Incorporation         Owned       
					  _____________    _________________

Britton & Koontz First National Bank       Federal Law           100%



							   NOTES


(1)     The Subsidiary is included in the consolidated financial statements. 
(2)     The Subsidiary conducts business under its own name.